Rare diseases
Investigational molecules
Locations
Back to France671 clinical trials in Bois-Guillaume, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis
FranceStudy on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis
FranceStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
FranceStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
FranceStudy of Rocatinlimab in Adults with Prurigo Nodularis Not Adequately Controlled by Topical Treatments
FranceStudy on Ibrutinib, CD20 Ab and Venetoclax for Patients with Untreated Mantle Cell Lymphoma
FranceComparing Two Oral Doses of macitentan (10 mg vs 75 mg) in Healthy Participants for Pulmonary Arterial Hypertension
FranceWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
FrancePhase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis
FranceA study to evaluate the effectiveness and safety of zasocitinib in patients with moderate to severe hidradenitis suppurativa
FranceEfficacy and Safety of Maintenance Cabozantinib Plus Best Supportive Care in Pediatric and AYA Patients with Unresectable Residual Osteosarcoma
FranceStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on chronic kidney disease treatments and transplant outcomes, including studies of novel medications like baxdrostat and tegoprubart for improving patient care.
Multiple trials evaluating new therapeutic approaches for transplant recipients and CKD patients.
Clinical investigations into treatments for various blood-related conditions, with emphasis on immune thrombocytopenia and thrombotic disorders.
Advanced studies combining established and experimental treatments for better patient outcomes.
Research examining treatment strategies for viral infections and optimization of antibiotic therapy, particularly in elderly populations.
Studies focused on improving treatment protocols and reducing antibiotic overuse.
Investigation of novel therapies for vasculitis and related autoimmune disorders, including targeted biological treatments.
Evaluating new treatment combinations to improve disease management and patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
